Seeking Alpha

Johnson & Johnson said to receive 3 $4B+ offers for Ortho unit

Johnson & Johnson (JNJ +0.2%) is said to have received 3 offers of at least $4B each for its Ortho Clinical Diagnostics unit from Danaher (DNR -0.1%), The Carlyle Group (CG +1.6%), and CVC Capital.

Previous reports speculated the unit could fetch as much as $5B.

From other sites
Comments (3)
  • Mike Serebrennik
    , contributor
    Comments (1038) | Send Message
    What would JNJ do with the money? Buyback? Special dividend? Buy something else? I am in favor of 1 & 2.
    13 Dec 2013, 09:50 PM Reply Like
  • xsilence
    , contributor
    Comments (30) | Send Message
    Danaher's ticker symbol is DHR.
    13 Dec 2013, 10:01 PM Reply Like
  • Steve98
    , contributor
    Comments (46) | Send Message
    My career at Ortho spans 19 years. I received my JNJ business training at ODI as it was known then. I can honestly say that my training in sales, marketing and manufacturing from the company has greatly enhanced my business understanding and desire to perform at the highest levels I could attain.
    For the 19 years I invested at Ortho I can say I always went to work with expectation and desire to do my best. The reward was fair compensation and a boatload of JNJ stock that I have held starting back in 1972. Needless to say I am pleased to have been part of an exceptional organization that delivered high quality products and outstanding service to the customer and communities where products were developed and manufactured.
    14 Dec 2013, 09:55 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs